Gifu, Japan
NCT Number: NCT01929473
Seroepidemiological Study of Pertussis and Other Infectious Diseases
Serum samples will be corrected twice from the same youth subjects with one year interval.
Seroincidence of pertussis will be estimated by the elevation of Ig-G-PT in paired sera from an identical individual.
The relationship between the incidence and the demographic data or medical history of the subjects will be discussed.
Looking for future studies?
Notify MeKey information
Conditions
Age range
12 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Students of junior high school, high schools or college in Gifu prefecture
- Students who can have the second blood drawing one year later
- Students (and their parent when students are underage) whose written consent is obtainable.
Exclusion criteria
- None
Treatment and study plan
Primary outcomes
-
IgG
Time frame: 0 day, 365 day (2 points)
Seroincidence of pertussis estimated by the elevation of Ig-G-PT in paired sera(0day, 365day).
Secondary outcomes
-
Incidence of Pertussis
Time frame: 0 day
Questionnaire
-
Antibodies of Varicella, Mumps and Rubella
Time frame: 0 day
Questionnaire
-
Infection Risk Factors Including Family Numbers, Living Space, With or Without a Cough Patient in the Surroundings, Medical History and Hospitalization
Time frame: 365 day
Questionnaire
Sponsors and collaborators
Lead sponsor
Gifu Prefecture Medical Association
Other
Collaborators
- Sanofi Pasteur S.A.
Registry information
Important dates
- Study start
- 2013
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- Aug 28, 2013
- Registry last updated
- Jul 12, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation With Bordetella Pertussis Using Controlled Human Infection
NCT06903221
Bacterial Infections, Bacterial Infections and Mycoses
Nijmegen, Netherlands
View Trial Details